April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Modulation of cytokine trans-signaling by microRNA-21 (miR-21)-mediated regulation of TACE/ADAM17 in the diabetic retina
Author Affiliations & Notes
  • Manuela Bartoli
    Ophthalmology, Georgia Health Sciences University, Augusta, GA
  • Folami Lamoke
    Ophthalmology, Georgia Health Sciences University, Augusta, GA
  • Sean Shaw
    Ophthalmology, Georgia Health Sciences University, Augusta, GA
  • Diana Gutsaeva
    Oral Biology, Georgia Regents University, Augusta, GA
  • Babak Baban
    Anesthesiology, Georgia Regents University, Augusta, GA
  • Footnotes
    Commercial Relationships Manuela Bartoli, None; Folami Lamoke, None; Sean Shaw, None; Diana Gutsaeva, None; Babak Baban, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1030. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Manuela Bartoli, Folami Lamoke, Sean Shaw, Diana Gutsaeva, Babak Baban; Modulation of cytokine trans-signaling by microRNA-21 (miR-21)-mediated regulation of TACE/ADAM17 in the diabetic retina. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1030.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Up-regulation of inflammatory cytokines and their receptors, soluble and membrane bound, is involved in the pathogenesis of diabetic retinopathy (DR). Here we have investigated the expression levels and activity of the metalloproteinase TACE/ADAM17 which serves as converting enzyme to cleave cytokines receptors and propagate inflammatory responses by cytokines trans-signaling. Furthermore, we have investigated the potential role of microRNA-21 (miR-21) in promoting TACE/ADAM17 disinhibition through suppression of tissue inhibitor of matrix-metalloproteinase 3 (TIMP3) gene expression.

Methods: Diabetic retinas were obtained from streptozotocin-induced diabetic rats (STZ-rats) and from human post-mortem samples obtained by Georgia Eye Bank. MiR-21 expression was measured by qPCR and in situ hybridization. QPCR and Western analyses were employed to measure the expression levels of TIMP3 and TACE/ADAM17. A commercially available kit was used to assess TACE/ADAM17 activity.

Results: TACE/ADAM 17 activity was significantly up-regulated in the diabetic retina of STZ-rats (at 4 and 8 weeks of hyperglycemia). Increased TACE/ADAM17 activity was also found in human post-mortem retinas of diabetic donors. QPCR and in situ hybridization demonstrated increased levels of miR-21in the diabetic rat and human retinas. Furthermore, retinal expression levels of TIMP3 were down-regulated in the diabetic retinas at both, mRNA and protein levels.

Conclusions: Our results show that the activity of TACE/ADAM17 is up-regulated in the diabetic retina and this effect correlated with increased miR-21 expression and consequent TIMP3 gene suppression. These data revealed the existence of a key regulatory pathway for cytokine trans-signaling and propagation of inflammatory processes in the diabetic retina.

Keywords: 499 diabetic retinopathy • 636 pathobiology • 557 inflammation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×